Could shedding assets spell a breakthrough for troubled GE?

Feb 25, 2019
General Electric today announced the sale of its biopharmaceutical business for more than $21 billion dollars. The buyer is Danaher Corporation, which happens to have been previously run by GE chief executive Larry Kulp, who served as chief executive at…